1. Home
  2. PLRX vs NMCO Comparison

PLRX vs NMCO Comparison

Compare PLRX & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.17

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Municipal Credit Opportunities Fund

NMCO

Nuveen Municipal Credit Opportunities Fund

HOLD

Current Price

$9.67

Market Cap

549.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLRX
NMCO
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
549.9M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
PLRX
NMCO
Price
$1.17
$9.67
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$2.67
N/A
AVG Volume (30 Days)
437.8K
334.1K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.97
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$9.70
52 Week High
$1.95
$11.00

Technical Indicators

Market Signals
Indicator
PLRX
NMCO
Relative Strength Index (RSI) 55.13 29.72
Support Level $1.12 N/A
Resistance Level $1.26 $10.86
Average True Range (ATR) 0.04 0.19
MACD 0.00 -0.03
Stochastic Oscillator 57.87 5.62

Price Performance

Historical Comparison
PLRX
NMCO

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

About NMCO Nuveen Municipal Credit Opportunities Fund

Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.

Share on Social Networks: